Approval · Notice of Compliance 79 · 2003
AMOXICILLIN: Notice of Compliance 79
Issued May 20, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 79
- Date
- May 20, 2003
- Company
- Clonmel Healthcare LimitedClonmel, Tipperary, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
- Canadian reference product
- AMOXIL (Wyeth-Ayerst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | 02241826 | Cancelled (Unreturned Annual) |
| AMOXICILLIN | 02241827 | Cancelled (Unreturned Annual) |
| AMOXICILLIN | 02243224 | Cancelled (Unreturned Annual) |
| AMOXICILLIN | 02243225 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 250 MG per CAP
- AMOXICILLIN TRIHYDRATE 500 MG per CAP
- AMOXICILLIN TRIHYDRATE 125 MG per 5ML
- AMOXICILLIN TRIHYDRATE 250 MG per 5ML